Skip to main content
. 2023 Jul 9;14(11):2085–2092. doi: 10.7150/jca.84854

Figure 2.

Figure 2

Prognostic comparison of 1,665 stage N1-3 NPC patients with and without LNN. (A) Overall survival, (B) Distant metastasis-free survival, (C) Locoregional relapse-free survival.